Arcellx to participate at the h.c. wainwright 2nd annual cell therapy virtual conference

Redwood city, calif.--(business wire)--arcellx, inc. (nasdaq: aclx), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the h.c. wainwright 2nd annual cell therapy virtual conference on tuesday, march 26, at 1:00 p.m. et. a live webcast of this discussion will be accessible from arcellx's website at www.arcellx.com in t.
ACLX Ratings Summary
ACLX Quant Ranking